Article

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in Glioblastoma

2022-11-09

Abstract excerpt

<title>Abstract</title> <p>Aggressiveness and drug resistant are major challenges in the clinical treatment of glioblastoma (GBM). Our previously research reported a novel candidate oncogene ribosomal protein L22 like 1 (RPL22L1). The aim of this study was to elucidate the potential role and mechanism of RPL22L1 in progression and temozolomide (TMZ) resistance of GBM. Online database, tissue microarrays and clini...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c1452e28-c29e-51f9-b466-cee3fc55da0d
DOI: 10.21203/rs.3.rs-2164442/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in GlioblastomaDOI 10.21203/rs.3.rs-2164442/v1Read

POLR2J is a potential biomarker for abnormal tumor progression, vorinostat sensitization, immune infiltration, and prognosis of glioblastoma multiformSemantic proximity Read

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signalingSemantic proximity Read

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transitionSemantic proximity Read

Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistanceSemantic proximity Read

KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling PathwaySemantic proximity Read

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathwaySemantic proximity Read

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of Notch signalingSemantic proximity Read

Loss of CD99L2 contributed to temozolomide resistance and glioblastoma tumorigenesis based on Genome-scale CRISPR/Cas9 screeningSemantic proximity Read

MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastomaSemantic proximity Read

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-RadiotherapySemantic proximity Read

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategiesSemantic proximity Read

RRM2 promotes the progression of human glioblastomaSemantic proximity Read